Replies to post #97347 on Biotech Values

[AlpineBV_Miller]

You're right on the screw up. I'm REALLY surprised they haven't made an edit to the proxy. I think it has something to do with Italian law and lead times for notification.

400M shares at $0.40 = $160M
400M shares at $0.30 = $120M

I'd be surprised if that gets the company through approval, you know, assuming...